Evidence map›Paper›PMID 17146058›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder.

Chun-Hyung Kim, Maureen K Hahn, Yoosook Joung, Susan L Anderson, Angela H Steele, Michelle S Mazei-Robinson, Ian Gizer, Martin H Teicher, Bruce M Cohen, David Robertson and 3 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03154359 (An Open-Label, Single- and Multi-Dose Study to Evaluate the Relationship Between the Pharmacokinetics, Pharmacodynamics, and Clinical Outcomes of Atomoxetine in CYP2D6 Extensive, Intermediate and Poor Metabolizers in Children With Attention Deficit/Hyperactivity Disorder), which is not on this map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03154359 completednot on this mapstarted 2017, after this paper: background citation

An Open-Label, Single- and Multi-Dose Study to Evaluate the Relationship Between the Pharmacokinetics, Pharmacodynamics, and Clinical Outcomes of Atomoxetine in CYP2D6 Extensive, Intermediate and Poor Metabolizers in Children With Attention Deficit/Hyperactivity Disorder

TypeobservationalSponsorChildren's Mercy Hospital Kansas CityRan2017 to 2022Enrolled51ConditionsADHDArmsAtomoxetine Hydrochloride
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it, 155 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. The Role of Gene-Gene Interaction BetweenChildren (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Chun-Hyung KimMolecular Neurobiology, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA.
Maureen K Hahn
Yoosook Joung
Susan L Anderson
Angela H Steele
Michelle S Mazei-Robinson
Ian Gizer
Martin H Teicher
Bruce M Cohen
David Robertson
Irwin D Waldman
Randy D Blakely
Kwang-Soo Kim
Vanderbilt University Medical Center · USVanderbilt University · USEmory University · USHarvard University · USInstitute of Neurobiology and Molecular Medicine · ITSungkyunkwan University · KR

Funding

Structural genomics of norepinephrine transportersP01HL056693 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DIEDRICH, ANDRE · 1997 to 2016
$30.8M
Transcriptional regulatory cascade of midbrain dopamine neuron development by PitR01MH048866 · NIMH · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI KIM, KWANG-SOO · 1998 to 2012
$3.7M
Genetic approach for transneuronal NA circuitry mappingR01DC006501 · NIDCD · MC LEAN HOSPITAL (BELMONT, MA) · PI KIM, KWANG-SOO · 2004 to 2008
$1.3M
MOLECULAR GENETICS OF CHILDHOOD DISRUPTIVE DISORDERSK01MH001818 · NIMH · EMORY UNIVERSITY · PI WALDMAN, IRWIN D · 2000 to 2004
$679k
Endophenotypes for Molecular Genetic Studies of ADHDF31MH072083 · NIMH · EMORY UNIVERSITY · PI GIZER, IAN ROBERT · 2004 to 2006
$50k
TRANSCRIPTIONAL MECHANISMS OF TH GENE EXPRESSIONR29MH048866 · NIMH · WINIFRED MASTERSON BURKE MED RES INST · PI KIM, KWANG-SOO · 1992 to 1996
–
NHLBI NIH HHS HL 56693NHLBI NIH HHS P01 HL056693NIDCD NIH HHS DC 006501NIDCD NIH HHS R01 DC006501NIMH NIH HHS F31 MH 072083NIMH NIH HHS F31 MH072083NIMH NIH HHS K01 MH001818NIMH NIH HHS K01 MH 01818NIMH NIH HHS MH 48866NIMH NIH HHS R01 MH048866NIMH NIH HHS R29 MH048866
6 · The paper itself

Abstract

The norepinephrine transporter critically regulates both neurotransmission and homeostasis of norepinephrine in the nervous system. In this study, we report a previously uncharacterized and common A/T polymorphism at -3081 upstream of the transcription initiation site of the human norepinephrine transporter gene [solute carrier family 6, member 2 (SLC6A2)]. Using both homologous and heterologous promoter-reporter constructs, we found that the -3081(T) allele significantly decreases promoter function compared with the A allele. Interestingly, this T allele creates a new palindromic E2-box motif that interacts with Slug and Scratch, neural-expressed transcriptional repressors binding to the E2-box motif. We also found that both Slug and Scratch repress the SLC6A2 promoter activity only when it contains the T allele. Finally, we observed a significant association between the -3081(A/T) polymorphism and attention-deficit hyperactivity disorder (ADHD), suggesting that anomalous transcription factor-based repression of SLC6A2 may increase risk for the development of attention-deficit hyperactivity disorder and other neuropsychiatric diseases.

Indexed as

AllelesAttention Deficit Disorder with HyperactivityBase SequenceDNAGene Expression RegulationHumansNorepinephrine Plasma Membrane Transport ProteinsPolymorphism, GeneticPromoter Regions, GeneticProtein BindingTranscription FactorsTranscription, GeneticZinc FingersDNANorepinephrine Plasma Membrane Transport ProteinsSLC6A2 protein, humanTranscription Factors

Identifiers

PMID17146058
PMCPMC1748193
OpenAlexW2007086168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.